Biological effects of cytokines are in part determined by their interactions in the regulation ofcytokine production. This study analyzes the effects of leukemia inhibitory factor (LIF) on cytokine expression in different cell lineages. Recombinant human LIF increases levels of IL-1i8, IL-6, and IL-8 mRNA in human articular chondrocytes as demonstrated by Northern blotting. These cytokine mRNAs are detectable as early as 13 h after stimulation and reach their maximum after 5 h. The LIF effects are dose dependent and of similar magnitude to those of IL-1. By metabolic labeling and immunoprecipitation it is shown that LIF induces synthesis and secretion of IL-6. IL-6 bioactivity in conditioned media, as measured by the B9 hybridoma proliferation assay, is increased by LIF. Effects of LIF on cytokine expression are not confined to connective tissue cells. By PCR it is shown that human blood monocytes express IL-6 mRNA after stimulation with LIF. An increase in IL-6 mRNA levels is detectable 2 h after stimulation, and this starts to decline by 5 h. The response is of shorter duration as compared with IL-1iB. In addition to increased mRNA expression, LIF also stimulates release of biologically active IL-6 from blood monocytes. In synoviocytes and neuronal as well as epithelial cell lines, LIF increases IL-1,8 and IL-6 gene expression. In summary, LIF induces cytokine expression in a wide variety of tissues. These results suggest that through the induction of cytokines, LIF can modulate inflammation, immune responses, and connective tissue metabolism, and act as a pathogenetic mediator in different disease states. (J. Clin. Invest. 1993. 91:1575-1581
Introduction
A characteristic property ofcytokines is their ability to regulate the expression ofother cytokines, and this interaction can mediate or modulate the biological effects of a particular cytokine. Leukemia inhibitory factor (LIF)' is a cytokine that was initially described on the basis of its ability to induce differentiation of murine myeloid leukemic cells (1) . It inhibits differen- 1 . Abbreviations used in this paper: GAPDH, glyceraldehyde 3-phosphate dehydrogenase; LIF, leukemia inhibitory factor; MCP-1, monocyte chemoattractant protein-1; OSM, oncostatin M; SP, substance P. tiation of pluripotent embryonal stem cells (2, 3) , induces the synthesis of hepatic acute phase proteins (4), promotes neuronal differentiation (5-7), inhibits lipoprotein lipase activity (8) , and regulates bone metabolism (9-1 1 ). LIF is produced by cells ofthe immune system (12) (13) (14) , thymic epithelial cells, fibroblasts, endothelial cells, and rat liver cells (15) (16) (17) (18) (19) . We recently identified human articular chondrocytes and synoviocytes as intraarticular sources of LIF (20) and showed that LIF is integrated into the cytokine network through its induction by IL-I and TNF. This study shows that LIF shares with IL-1 and TNF the ability to induce cytokine production in different cell types.
Methods

Cell isolation and culture
Chondrocytes. Cartilage was obtained at autopsy or from the University of California, San Diego tissue bank from donors without known history of joint disease. For all experiments reported here, cartilage from the femoral condyles and tibial plateaus of the knee joints was used. Cartilage slices were prepared, washed with DMEM (Whittaker MAB Bioproducts, Walkersville, MD), minced with a scalpel, and treated with trypsin (10% vol/vol) for 15 min in a 370C water bath. The samples were digested in DMEM containing 5% FBS, penicillinstreptomycin-fungizone, and 2 mg/ml clostridial collagenase type IV (Sigma Immunochemicals, St. Louis, MO). The cells were washed three times and cultured as primary chondrocytes at high cell density (4 X 106 cells per T175 flask).
Monocytes. PBMCs were isolated from heparinized blood by Ficoll-Hypaque density gradient sedimentation. Monocytes were isolated by adherence to gelatin-coated culture dishes that were preincubated with autologous plasma. The plates were washed to completely remove nonadherent cells. Puck's EDTA solution was added, the plates were incubated at 4°C for 20 min, and the monocytes were collected by gently scraping with a rubber policeman. For in vitro culture, cells were resuspended at 106/ml in RPMI 1640 containing 1% FBS, L-glutamine, and penicillin-streptomycin and plated at 106 per well in six-well tissue culture plates.
Synoviocytes. Synoviocytes were isolated from rheumatoid arthritis synovial tissues and cultured as described (21) . The cell lines were established from the adherent primary cell populations that contain monocyte-and fibroblast-like cells.
Cell lines
The human cell lines A549 (lung carcinoma) and U373 (glioblastomaastrocytoma) were obtained from the American Type Culture Collection (Rockville, MD) and maintained in DMEM containing 10% FBS.
IL-6 bioassay
The B9 hybridoma proliferation assay was used to measure IL-6 as previously described (21) . and incubated in cysteine-and methionine-free RPMI (ICN Biomedicals, Inc., Costa Mesa, CA) supplemented with L-glutamine, penicillinstreptomycin, 1% FBS, [35S]cysteine, and [35S]methionine (100 MCi/ ml; ICN Biomedicals, Inc.) for 48 h. The supernatants were collected and precleared by incubating with protein A Sepharose (Zymed Laboratories, Inc., S. San Francisco, CA) for 1 h. The samples were incubated overnight in the presence of 5 ,l of antibody to IL-6 (rabbit IgG, 1 mg/ml) on a rotor, and protein A Sepharose was added for an additional 2 h. The precipitates were washed five times with PBS containing 0.05% Tween-80, 0.1% Triton X-100, and 1 mM PMSF followed by two washes in PBS. The beads were boiled for 5 min in Laemmli sample buffer and the proteins were separated on 12.5% polyacrylamide gels under reducing conditions. After staining with Coomassie blue, the gels were treated with Amplify (Amersham Corp., Arlington Heights, IL) for 1 h, dried, and exposed to Kodak XAR film (Eastman Kodak Co., Rochester, NY) at -70'C for 24 h.
RNA probe preparation
The 600-bp HindIII-Dral fragment ofthe IL-6 cDNA was inserted into the transcription vector pGEM-3Z (Promega Corp., Madison, WI). The cDNA for IL-8 was kindly provided by Dr. K. Matsushima (Kanazawa University, Ishikawa, Japan). A 500-bp fragment was subcloned into the EcoRI site of pGEM-3z, and its identity with the template cDNA was confirmed by dideoxy sequencing using T7 DNA polymerase (Pharmacia LKB Biotechnology Inc., Piscataway, NJ). For development of a probe for (3- 
Northern blot hybridization
Primary chondrocytes were maintained in T175 flasks for [4] [5] [6] [7] d. Before stimulation, cells were serum-starved for 24 h. Total RNA was extracted by the single-step guanidinium thiocyanate-phenol-chloroform method (22). 10-30 ,g oftotal RNA was separated on 1% formaldehyde gels, blotted onto nylon filters, and crosslinked with ultraviolet light for 5 min on each side. The blots were prehybridized in 50% formamide, 6x SSC, 0.5% SDS, 0.1% Tween-20, and 100 tgtRNA/ml for 15 min at 65°C. The prehybridization mixture was replaced with fresh solution containing 106 cpm/ml ofprobe. Hybridization was performed overnight at 65°C and followed by two 30-min washes in lX SSC, 0.1% SDS at room temperature and two 30-min washes in 0.1 X SSC, 0.1% SDS at 65°C. The damp filters were exposed to Kodak XAR film at -70°C for 2-24 h. To confirm equal RNA load and complete transfer the 18S and 28S bands were visualized with ethidium bromide.
In addition, RNA load was examined by probing for fl-actin mRNA. PCR for cytokines In some studies PCR was performed with [ 32p] dCTP in 25 cycles, which in separate experiments was shown to be within the linear range of amplification for both IL-6 and GAPDH. PCR products were separated on 8% acrylamide gels. The IL-6 and GAPDH bands were cut out and solubilized in scintillation liquid, and radioactivity was counted.
Reagents
The following reagents were used: IL-lI#, LIF, and rabbit antibody to 
Results
LIF induces IL-6 and IL-8 mRNA expression in chondrocytes.
Primary human articular chondrocytes were serum-starved for 24 h to avoid interference of serum components with mRNA induction by the specific cytokines. Cells were then stimulated with LIF and RNA was analyzed by Northern blotting. ILiB -
GPDH -
IL-1 is a well-characterized and potent inducer of IL-6 and IL-8 in chondrocytes (23) . Fig. 1 (24) . As monocytes are an important source of cytokines, we tested whether LIF can induce the expression ofproinflammatory cytokines in this cell type. Fig. 3 shows the results from PCR analysis for IL-6 expression. Low levels of IL-6 mRNA were detected in 1 23 4 5 67 89 PCR analysis with 32P-labeled nucleotides showed that IL-6 mRNA increase -10-fold in the presence of LIF at 50 and 10 ng/ml under conditions where the levels of GAPDH radiolabeled PCR product were constant (not shown). Sequencing of PCR product that was obtained with the IL-6 primers confirmed that it had the expected nucleotide composition of the IL-6 gene between positions 43 and 507.
IL-6 is de novo synthesized in response to LIF. Having shown that LIF can induce cytokine mRNA expression, we analyzed whether gene expression resulted in a corresponding increase in protein synthesis. Subcultured (passage 1) or primary chondrocytes were serum-starved for 24 h and then stimulated with LIF at concentrations between 10 and 50 ng/ml. Conditioned media were harvested after 48 h and IL-6 was immunoprecipitated and analyzed by SDS-PAGE. The effects of IL-I/ are shown for comparison. In both cell populations (subcultured cells, lanes 1-5; primary chondrocytes, lanes 6-10) LIF induced dose-dependent synthesis and secretion of IL-6 proteins which were detected as the characteristic bands between 20 and 30 kD, representing the different molecular forms of IL-6 (Fig. 4) . The relative intensity of these bands is similar in IL-1I-or LIF-treated cells. Thus, LIF not only leads was measured by PCR as described in Fig. 2 . Lanes 1 and 7, unstimulated; lanes 2 and 8, 1 ,ug/ml LPS; lanes 3 and 9, 10 ng/ml IL-1; lanes 4 and 10, 50 ng/ml LIF; lanes 5 to a rapid expression of IL-6 mRNA but it also induces synthesis and secretion of IL-6 proteins.
LIF increases IL-6 bioactivity in conditioned media. To test whether IL-6 in conditioned media from LIF-treated cells was biologically active, IL-6 activity was measured in the B9 hybridoma proliferation assay. LIF induced a dose-related increase in IL-6 bioactivity in 24-h chondrocyte cultures to levels similar to those found in IL-1I3-stimulated cultures (Fig. 5 ) . At lower doses (0.1 ng/ml) IL-Ifl appeared to be more potent than LIF. Low levels of IL-6 activity were found in 24-h conditioned media from adherent blood monocyte cultures. LIF caused a maximal 10.5-fold increase in IL-6 levels. The maximal IL-1 # effect was a 13.4-fold stimulation of IL-6. Collectively, these results show that LIF induces synthesis and secretion ofbiologically active IL-6 in monocytes and chondrocytes.
Since LIF can stimulate IL-l expression and IL-1 is a potent inducer of IL-6, it was possible that the LIF effect was dependent on IL-1. Fig. 6 shows that the LIF induction was almost completely inhibited by antibody to LIF but not by anti-IL-I or preimmune rabbit IgG. The antibody to IL-1 was biologically active since it was able to reduce the IL-1 effect on IL-6 expression. These findings suggest that the induction of IL-6 is a direct function of LIF. In addition, these results also demonstrate that the induction of IL-6 was not due to the presence of endotoxin in the LIF preparation used.
LIF induction ofcytokines in other cell types. To determine whether the effects of LIF on cytokine expression are restricted to particular cell types or represent a general response in different tissues, human rheumatoid synoviocytes, glioblastoma, and lung epithelial cells were stimulated with LIF and probed for the expression of different cytokine mRNAs. LIF induced a dose-related increase in IL-6 mRNA expression in synoviocytes, in the epithelial cell line A549, and in the glioblastoma cell line U373 (Fig. 7) . The increase in mRNA levels in all cell lines induced by LIF and IL-1If was of similar magnitude. LPS had only weak or no effects on IL-6 expression in synoviocytes and A549 and U373 cells, which suggests that the ability ofLIF to induce cytokine mRNAs is not due to the presence of small amounts of endotoxin. In addition to IL-6, LIF also induced the expression of mRNAs for IL-1,B and the monocyte chemoattractant protein-in these different cell types (not shown).
For better quantification of the LIF effects on IL-6 mRNA levels, PCR for IL-6 and GAPDH was performed in the presence of [ 32p]dCTP for 25 cycles, which in separate experiments was shown to be within the linear range of amplification for both IL-6 and GAPDH. The results in Fig. 8 , which were normalized on the basis of the counts for GAPDH, show that LIF caused a dose-dependent increase in IL-6 mRNA which was 10.3-, 11.2-, and 2.7-fold, respectively, at the three different concentrations of LIF used.
Discussion
This study shows that LIF induces expression ofproinflammatory cytokines. Human articular chondrocytes express IL-1#, IL-6, and IL-8 mRNA and synthesize and secrete biologically active IL-6 in response to LIF. Similar effects were found in human blood monocytes, synoviocytes, and epithelial and neuronal cell lines. Through the induction of these cytokines in diverse cell types LIF has the potential to initiate and propagate inflammatory and immunological responses.
LIF is a cytokine that regulates differentiation of a wide variety ofcell types including embryonic stem cells and hematopoietic and neuronal cells (25) . More recently, it was recognized that LIF also regulates bone metabolism in vitro and in vivo (9) (10) (11) and that it induces expression of hepatic acute phase proteins (4) . Other functions include the inhibition of lipoprotein lipase activity (8) and the increase in neuronal substance P (SP) expression (26).
Although LIF does not share sequence homology with IL-6, these two cytokines have some similar functional properties. Both augment proliferation of hematopoietic stem cells (27) and induce differentiation of murine Ml leukemic cells (28) . Furthermore, IL-6 and LIF induce expression ofa similar set of acute phase proteins in hepatocytes (4, 29) . These findings could be explained by a reciprocal induction of the two cytokines, but in hematopoietic cells this mechanism has been ruled out using neutralizing antibodies (27) . Another explanation for functional similarities is the possibility that LIF and IL-6 stimulate similar intracellular signals. This hypothesis was supported by the characterization of the LIF receptor (30) , which has structural homology with the IL-6 signal transducer, gpl 30 . Furthermore, the same immediate early pattern ofgene expression has been observed upon induction of myeloid leu- kemia cell differentiation by IL-6 and LIF (31 ) . Oncostatin M (OSM) (32) has effects similar to those of IL-6 and LIF on hepatocytes and murine myeloid leukemia cells and, although this has not been formally demonstrated, it is conceivable that other cell types show similar responses to LIF and OSM. This notion is based on the recent demonstration that the high affinity receptor for LIF, which is composed ofthe IL-6 signal transducer gp 130 and the LIF receptor-a chain, is also a high affinity OSM receptor (33). IL-I and IL-6 share some biological effects, but there are also important functional differences. These include the induc- IL-6 (pg/ml) Figure 6 . LIF induction of IL-6 is not IL-I dependent. 5 ng/ml LIF or 1 ng/ml IL-I was preincubated with specific neutralizing antibody or preimmune rabbit IgG (all at 10 Ag/ml) or in media only. Arthritis is one example of many diseases where this LIF effect can contribute to pathogenesis. Cartilage is the final target of joint inflammation. Independent from the underlying disease processes, inflammation results in destruction of cartilage leading to impairment of joint function and arthrosis. Chondrocytes are now known to actively participate in regulation of inflammatory reactions through the production of a broad range of cytokines and growth factors (20, 23, 36, 37 (20) where mRNA was primarily localized in interstitial cells. For the analysis of LIF effects on cytokine expression in synoviocytes we did not detect constitutive levels of cytokine mRNAs, which can be found in freshly isolated rheumatoid synovium. In this study we used cells that had been cultured in the absence of serum for 24-48 h to avoid contribution ofserum factors to the LIF effect on the induction of other cytokines. As LIF can induce expression of the two chemoattractant proteins, IL-8 and MCP-1, an indirect role ofLIF in recruitment ofinflammatory cells which are typically present in joint inflammation can be proposed. Furthermore, LIF could enhance the proinflammatory functions ofthe invading monocytes as it induces cytokine expression in these cells.
With its effects on chondrocytes and synoviocytes LIF can contribute to pathogenesis of arthritis. However, through the ability to stimulate cytokine production in mononuclear phagocytes, LIF is a pathogenetic mediator in diverse disease states. LIF had originally been described as an inducer of monocyte differentiation of the murine Ml myeloid leukemia cell line ( 1 ) . However, although LIF receptors have been found on macrophages, monocytes, and their precursors (24), no effect of LIF on mature monocytes has been described. The present findings of LIF induction of IL-6 mRNA and IL-6 activity are the first demonstration of LIF effects on mature monocytes. The PCR products were separated on acrylamide gels and excised, and radioactivity was quantified by scintillation counting. Results are shown as counts per minute of IL-6 PCR product, which were normalized on the basis of the counts for GAPDH. has the potential to be a pathogenetic mediator in diverse disease states.
